Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

about

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.

P2860

Q37283438-7AD57D90-474C-4D04-8CD7-9D319E3917D5

P2860

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

Item

http://www.wikidata.org/entity/Q40878292

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Impact of tiotropium + olodate ...... pen-label observational study.

@en

type

Item

label

Impact of tiotropium + olodate ...... pen-label observational study.

@en

prefLabel

Impact of tiotropium + olodate ...... pen-label observational study.

@en

P1476

Impact of tiotropium + olodate ...... pen-label observational study.

@en

P2093

Marcel Frey

http://www.w3.org/2001/XMLSchema#string

Michaela Hänsel

http://www.w3.org/2001/XMLSchema#string

Roland Buhl

http://www.w3.org/2001/XMLSchema#string

Roman A Rubin

http://www.w3.org/2001/XMLSchema#string

Rüdiger Sauer

http://www.w3.org/2001/XMLSchema#string

Thomas Glaab

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Performance of health-status scales when used selectively or within multi-scale questionnaire

The MOS 36-ltem Short-Form Health Survey (SF-36)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations

Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.

Validity of 24-h physical activity recall: physical activity measurement survey.

Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice.

The effect of social desirability and social approval on self-reports of physical activity.

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.

Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.

P304

891-898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S103023

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217742

http://www.w3.org/2001/XMLSchema#string

P932

4853152

http://www.w3.org/2001/XMLSchema#string

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

about

P2860

P2860

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932